Global Head of Marketing, Immunology LCM

Introduction to Role

Our ambition is to deliver lifechanging medicines that achieve clinical remission in immunemediated diseases. Building on the launch of biologic medicinefor systemic lupus erythematosus (SLE) we are expanding into additional indications through a robustlifecycle management (LCM)program. This role within theGlobal Immunologyteam will lead development and commercialization for select new indications bringing differentiated value to new customer groups and ensuring shortterm launch success while maximizing longterm brand value.

Accountabilities

• Lead and develop the global commercial strategy for select new indications aligned to franchise priorities and brand positioning with ownership of detailed prelaunch planning and critical path management starting at leastT24 months prelaunch.
• Direct integrated insights and analytics (withGIBEXand regional partners) to deeply understand market dynamics patient journeys unmet need behavior and barriers in target indications.
• Continuously monitor the competitive landscape for target indications; identify opportunities and risks; and adapt strategy and resourcing to achieve ambitious launch and growth objectives.
• Orchestrate crossfunctional collaboration acrossMedical AffairsPricing & Market AccessMarket DevelopmentRegulatoryR&D andAdvocacyto secure timely delivery of evidence access and promotional readiness aligned to launch objectives.
• Define and deliver commercialization content tailored to new customer groups while maintaining coherence with the overarching brand strategy and scientific platform.
• Own indication budgets; ensure costeffective investments and prioritization to maximize impact under resource constraints; track performance and coursecorrect.

Essential Skills/Experience (MustHave)

• Deep immunology expertise is required with handson experience in launch commercialisation of monoclonal antibody or other targeted advanced therapies in at least one of:Rheumatology (eg: RA SpA SLE) Dermatology (eg: PsO AD HS) or Gastroenterology (eg: Crohns UC); candidates without substantial immunology experience will not be considered.
• Proven leadership ofglobal launches including ownership ofT24 month prelaunch planning integrated gotomarket frameworks and operational execution across multiple regions.
• Demonstrated experience inlifecycle management (LCM) of Phase 2 / 3 assets including indication expansion strategies evidence planning label optimization and postlaunch growth acceleration.
• Meaningful engagement with external scientific experts and professional societies with a track record ofadvocacy developmentin new indications (e.g. data generation alignment guideline influence and KEE/HCP mobilization).
• Strong understanding ofdevelopment and regulatory frameworksacross key regions (USA Europe Japan China) and a proven history of effective collaboration withR&Dto align development pathways and regulatory strategy with commercial objectives.
• Robust fluency inP&L forecasting and thefinancial driversof new indication launches (pricing access demand creation and retention).
• Demonstrated ability to mobilize teams energize stakeholders and build momentum behind new indications balancing scientific rigor with commercial pragmatism.
• 15 yearsof pharmaceutical commercial experience including global and local roles.
• Bachelors degree(business marketing or life sciences); advanced degree preferred.

Preferred Qualifications

• Prior launch leadership for biologics or targeted immunology therapies
• Track record of success in complex access environments including innovative contracting or valuebased approaches.

Key Competencies

• Strategic agility: Ability to translate science and market insight into differentiated positioning and scalable launch frameworks.
• Crossfunctional leadership: Skilled at aligning diverse stakeholders and driving accountable execution.
• Datadriven decision making: Comfort with triangulating market research realworld data and performance analytics to inform choices.
• Communication excellence: Clear compelling narratives to influence senior leaders affiliates and external partners.

Date Posted

Closing Date